Proteomics, Max Planck Institute of Biophysics, Max-von-Laue-Strasse 3, 60438 Frankfurt am Main, Germany.
Proteomics, Max Planck Institute for Brain Research, Max-von-Laue-Strasse 4, 60438 Frankfurt am Main, Germany.
J Am Soc Mass Spectrom. 2022 Jul 6;33(7):1293-1302. doi: 10.1021/jasms.2c00102. Epub 2022 Jun 27.
Identification and sequence determination by mass spectrometry have become routine analyses for soluble proteins. Membrane proteins, however, remain challenging targets due to their hydrophobicity and poor annotation. In particular small membrane proteins often remain unnoticed as they are largely inaccessible to Bottom-Up proteomics. Recent advances in structural biology, though, have led to multiple membrane protein complex structures being determined at sufficiently high resolution to detect uncharacterized, small subunits. In this work we offer a guide for the mass spectrometric characterization of solvent extraction-based purifications of small membrane proteins isolated from protein complexes and cellular membranes. We first demonstrate our Top-Down MALDI-MS/MS approach on a Photosystem II preparation, analyzing target protein masses between 2.5 and 9 kDa with high accuracy and sensitivity. Then we apply our technique to purify and sequence the mycobacterial ATP synthase subunit, the molecular target of the antibiotic drug bedaquiline. We show that our approach can be used to directly track and pinpoint single amino acid mutations that lead to antibiotic resistance in only 4 h. While not applicable as a high-throughput pipeline, our MALDI-MS/MS and ISD-based approach can identify and provide valuable sequence information on small membrane proteins, which are inaccessible to conventional Bottom-Up techniques. We show that our approach can be used to unambiguously identify single-point mutations leading to antibiotic resistance in mycobacteria.
通过质谱鉴定和序列测定已经成为可溶性蛋白质的常规分析方法。然而,由于膜蛋白的疏水性和注释较差,它们仍然是具有挑战性的目标。特别是小膜蛋白通常由于其大部分无法被 Bottom-Up 蛋白质组学方法检测到,因此往往被忽视。尽管如此,结构生物学的最新进展已经导致多个膜蛋白复合物结构在足够高的分辨率下被确定,以检测未表征的小亚基。在这项工作中,我们提供了一种用于从蛋白质复合物和细胞膜中分离的小膜蛋白的基于溶剂萃取的纯化的质谱鉴定指南。我们首先在 Photosystem II 制剂上展示了我们的 Top-Down MALDI-MS/MS 方法,以高精度和高灵敏度分析 2.5 至 9 kDa 之间的目标蛋白质量。然后,我们将我们的技术应用于纯化和测序分枝杆菌 ATP 合酶亚基,该亚基是抗生素药物贝达喹啉的分子靶标。我们表明,我们的方法可以在仅 4 小时内直接跟踪和定位导致抗生素耐药性的单个氨基酸突变。虽然不适用于高通量流水线,但我们的 MALDI-MS/MS 和基于 ISD 的方法可以识别和提供小膜蛋白的有价值的序列信息,这些信息是传统的 Bottom-Up 技术无法获得的。我们表明,我们的方法可用于明确鉴定导致分枝杆菌抗生素耐药性的单点突变。